Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BY-NC-ND 4.0Scientific Reports

Using artificial intelligence for clinical trial quality assurance in a multi-institutional neurovascular-sparing prostate radiotherapy trial

1 more authors

Related

  1. Artificial intelligence in image-guided cervical interventional radiotherapy: a systematic review
    Valentina Lancellotta, Angeles Rovirosa, Maria Concetta La Milia +12
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textApplied physics & instrumentationCrossrefEurope PMCEurope PMCPMC
  2. Deep learning-based self-supervised detection and localization of magnetic resonance imaging anomalies in artificial intelligence-supported radiotherapy workflows
    Mustafa Kadhim, Viktor Rogowski, Emilia Persson +7
    arXivPreprintarXiv licenceFull textBiological & medical physicsarXiv
  3. Six-year data from three magnetic resonance-guided radiotherapy systems demonstrate long-term stability of linear accelerator quality assurance
    Guido C. Hilgers, Simon J. Woodings, Thomas A. Foppen +4
    Physics and Imaging in Radiation OncologyPeer-reviewedCC BY 4.0Full textApplied physics & instrumentationPMCEurope PMC
  4. Beyond Gamma Analysis: An Accessibility-oriented Framework for Comparative Evaluation of Patient-specific Radiotherapy Quality Assurance
    Vikram, Raj Pal Singh, Manindra Bhushan
    Journal of Medical PhysicsPeer-reviewedCC BY-NC-SAFull textApplied physics & instrumentationDOAJ
  5. Radiation therapy quality assurance (RT QA) of adjuvant fractionated radiotherapy for WHO grade 2 atypical meningioma in the ROAM/EORTC1308 trial
    Helen M.O. Mayles, Brian J. Haylock, Gillian Whitfield +5
    Clinical and Translational Radiation OncologyPeer-reviewedCC BY-NC-NDFull textApplied physics & instrumentationDOAJEurope PMCEurope PMCPMC
BibTeX
@article{doucette2026using,
  title = {{Using artificial intelligence for clinical trial quality assurance in a multi-institutional neurovascular-sparing prostate radiotherapy trial}},
  author = {Matthew Doucette and Ying Zhang and Chien-Yi Liao and Mu-Han Lin and Yulong Yan and Robert T. Dess and Rahul D. Tendulkar and Aurelie Garant and Raquibul Hannan and Steve Jiang and Dan Nguyen and Neil B. Desai and Daniel X. Yang},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-77716-x},
  url = {https://www.nature.com/articles/s41598-026-77716-x},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Using artificial intelligence for clinical trial quality assurance in a multi-institutional neurovascular-sparing prostate radiotherapy trial
AU  - Matthew Doucette
AU  - Ying Zhang
AU  - Chien-Yi Liao
AU  - Mu-Han Lin
AU  - Yulong Yan
AU  - Robert T. Dess
AU  - Rahul D. Tendulkar
AU  - Aurelie Garant
AU  - Raquibul Hannan
AU  - Steve Jiang
AU  - Dan Nguyen
AU  - Neil B. Desai
AU  - Daniel X. Yang
PY  - 2026
DA  - 2026/10/28
JO  - Scientific Reports
DO  - 10.1038/s41598-026-77716-x
UR  - https://www.nature.com/articles/s41598-026-77716-x
SN  - 2045-2322
ER  -